Physician profile
Bridget Akel
NPI 1407080559
$441.60
in general payments reported to CMS, 2019-2025
15 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $345 · 2023: $17.04 · 2024: $79.47.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $96.51.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $96.51 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $77.32 | 2019 | |
| Lilly USA, LLC | $55.41 | 2019 | |
| Valeritas, INC. | $52.43 | 2019 | |
| Abbvie INC. | $46.32 | 2019 | |
| Insulet Corporation | $39.44 | 2019-2024 | Omnipod |
| Glaxosmithkline, LLC. | $32.09 | 2023-2024 | Jemperli, Zejula |
| Mannkind Corporation | $23.04 | 2019 | |
| Novo Nordisk INC | $21.82 | 2019 | |
| Abbott Laboratories | $20.73 | 2024 | Freestyle Libre 3 |
| Ibsa Pharma INC. | $17.95 | 2024 | Licart, Tirosint |
| Amgen INC. | $15.08 | 2019 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $14.57 | 2019 | |
| Pfizer INC. | $12.33 | 2019 | |
| Radius Health, INC. | $11.29 | 2019 | |
| Cequr Corporation | $1.78 | 2023 | Cequr Simplicity |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Bridget Akel listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.